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Abstract
Background: Neuromyelitis optica (NMO) is considered relatively more common in non-Whites, whereas multiple sclerosis
(MS) presents a high prevalence rate, particularly in Whites from Western countries populations. However, no study has
used ancestry informative markers (AIMs) to estimate the genetic ancestry contribution to NMO patients.
Methods: Twelve AIMs were selected based on the large allele frequency differences among European, African, and
Amerindian populations, in order to investigate the genetic contribution of each ancestral group in 236 patients with MS
and NMO, diagnosed using the McDonald and Wingerchuck criteria, respectively. All 128 MS patients were recruited at the
Faculty of Medicine of Ribeira˜o Preto (MS-RP), Southeastern Brazil, as well as 108 healthy bone marrow donors considered as
healthy controls. A total of 108 NMO patients were recruited from five Neurology centers from different Brazilian regions,
including Ribeira˜o Preto (NMO-RP).
Principal Findings: European ancestry contribution was higher in MS-RP than in NMO-RP (78.5% vs. 68.7%) patients. In
contrast, African ancestry estimates were higher in NMO-RP than in MS-RP (20.5% vs. 12.5%) patients. Moreover, principal
component analyses showed that groups of NMO patients from different Brazilian regions were clustered close to the
European ancestral population.
Conclusions: Our findings demonstrate that European genetic contribution predominates in NMO and MS patients from
Brazil.
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Introduction
Neuromyelitis optica (NMO) and multiple sclerosis (MS) have
been reported in all continents in various distinct populations [1–
4]. NMO has been referred to as a rare disease which is more
frequently observed among non-White individuals. In contrast,
MS presents a high prevalence rate, particularly in Whites from
Western countries populations, exhibiting a latitudinal gradient
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variation and being more frequent in Northern areas and less
frequent towards Equatorial areas [3,5–7].
Ancestry informative markers (AIMs) have been used as a
robust tool to adjust for population admixture, controlling
population stratification and avoiding spurious associations in
case-control studies [8,9]. Until now, no study has used AIMs to
estimate the genetic contribution of each ancestral population to
NMO. In this context, due to its genetically diverse background
after five centuries of intense interethnic crossing of individuals of
European, African, and Amerindian ancestry, the Brazilian
population has been suitable for this proposal. Here we
investigated the European, African, and Amerindian genetic
ancestry contribution in NMO and MS Brazilian patients.
Materials and Methods
Ethics Statement
This study was approved by Ethics Research Committee at
Faculty of Medicine of Ribeira˜o Preto, University of Sa˜o Paulo,
and each subject provided written informed consent.
Subjects
A total of 128 MS and 108 NMO patients, diagnosed using the
McDonald and Wingerchuck criteria, respectively [4,10], were
included in the study. All MS patients were recruited at the
University Hospital of the Faculty of Medicine of Ribeira˜o Preto,
University of Sa˜o Paulo, Brazil, as well as 108 healthy bone
marrow donors. NMO patients were recruited from five Neurol-
ogy centers from different Brazilian regions: 87 from the
Southeastern region [58 from Ribeira˜o Preto (NMO-RP), 12
from the city of Sa˜o Paulo (NMO-SP), and 17 from the city of Belo
Horizonte (NMO-BH)]; seven patients from the Central region
(Goiaˆnia, NMO-GO ), and 14 from the Northeastern region
(Recife, Pernambuco, NMO-PE). Patients exhibiting Asian
ancestry were excluded in the cohort studied. There were no
Asian descendants in the MS cohort, and the only four Japanese
descendants in the NMO cohort were excluded from the analysis.
Ancestral Population Genotypes
Genotype data from African (n=128) and European (n=88)
populations were kindly provided by Dr. Mark D. Shriver.
Brazilian Amerindian genotype data, primarily encompassing
representative individuals from Tikuna tribe (n = 48), were
retrieved from a previous study which described the genotypes
of 309 individuals from four Amazon tribes [11].
Ancestry Informative Markers (AIMs) Selection and
Genotyping
Twelve AIMs were selected based on the large allele frequency
differences among European, African, and Amerindian popula-
tions (Table 1): FY-NULL*1, RB1*1, LPL*1, AT3*1, and APOA*1
discriminate Africans from Amerindians and Europeans; PV92*1,
CKM*1, DRD2-BclI*1, MID-52*1, and MID-575*1 discriminate
Amerindians from Africans and Europeans; MID-93*1 differen-
tiates Europeans from Africans and Amerindians; and SB19.3*1
differentiates Africans from Europeans, as previously reported [9].
FY-NULL*1, RB1*1, LPL*1, AT3*1, APOA*1, and PV92*1, and
SB19.3*1 were genotyped as previously reported [11]. CKM*1 and
DRD2-BclI*1 single nucleotide polymorphisms were identified
using PCR-amplified DNA digested with TaqI and BclI (New
England Biolabs, Ipswitch, MA). MID-52*1, MID-575*1, and
MID-93*1 indel polymorphisms were identified using PCR-
amplified DNA, followed by direct detection in polyacrylamide
gels after silver nitrate staining. Primers were designed using the
Primer3 web interface (http://frodo.wi.mit.edu/primer3/).
Statistical Analysis
Allele frequency estimates, deviations from Hardy-Weinberg
equilibrium expectations and the exact test of population
differentiation based on allele or genotype frequencies were
performed using GENEPOP software (http://genepop.curtin.
edu.au). Significant allele frequency differences were considered
when d values were greater than 0.30. Principal component
analysis (PCA) plot was generated based on allele frequencies using
MVSP 3.1 software (http://www.kovcomp.co.uk/mvsp/index.
html). Ancestry estimates were evaluated based on the gene
identity method that takes into account allele frequencies in
admixed population in comparison with those observed in
ancestral populations, using ADMIX95 program (http://www.
genetica.fmed.edu.uy/software.htm).
Multilocus genotypes were used to infer the proportion of the
ancestral population contribution to each individual by applying
the clustering algorithm implemented at Structure 2.3.3 software
(http://pritch.bsd.uchicago.edu/structure.html), and ancestry pro-
portions were represented using triangle plots. The admixture
model, correlated allele frequencies, and the following parameters
were considered: i) 30.000 burn-in interactions followed by
100.000 additional Markov Chain Monte Carlo interactions, ii)
a predefined K = 3 setting for the number of populations.
According to the obtained results, African ancestry indexes (AAI)
were estimated for each individual. AAI was expressed as the
logarithm of the ratio between the likelihood of a given multilocus
genotype occurring in the African population and the likelihood of
the multilocus genotype occurrence in the European plus
Table 1. Demographic, clinical and laboratory findings of neuromyelitis optica (NMO) and multiple sclerosis (MS) Brazilian patients.
NMO MS p-value
N=108 N=128
Gender ratio ( Female/male) 5.4 2.2 0.002
Age of onset, years (mean 6 SD) 35.00 (6 15.25) 30.46 (6 10.52) 0.01
Duration of disease, years (mean ± SD) 11.05 (6 7.4) 14.82 (6 7.2) 0.001
Laboratory
NMO-IgG (n=96)
Reagent 61 (63,54%) –
doi:10.1371/journal.pone.0058925.t001
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Amerindian populations. Since the variance of AAIs did not follow
normal distributions, the non-parametric Kruskal-Wallis test and
the Dunn’s multiple comparison post-test were performed using
GraphPad Prism software (http://www.graphpad.com/) to com-
pare African ancestry in NMO and MS patients.
Results
Demographic information for NMO and MS cohorts are
presented in Table 1. NMO patients were older at disease onset
and exhibited shorter disease duration compared with MS patients
(p,0.001 and p,0.01, respectively). The female/male ratio was
greater in the NMO group (5.4) in comparison with MS (2.2,
p,0.0002). Among NMO patients who were screened for NMO-
IgG, 63% presented seropositive NMO-IgG (61/96). Twelve
patients were not screened.
Allele frequencies for the 12 AIMs in ancestral populations and
in NMO, MS, and healthy controls from Ribeira˜o Preto (CTRL-
RP) are shown in Table 2. Deviation from the Hardy-Weinberg
equilibrium was observed only for the SB19.3 AIM in both MS
and NMO patients. The 12 AIMs selected were very informative
and able to differentiate ancestral populations. Differences in allele
frequencies between ancestral populations exhibited d values
greater than 0.30 (See Table 2). The multilocus genotype
information of these AIMs was able to discriminate among the
ancestral populations. Three totally divergent clusters were
obtained without any overlap, each group clustered in one of
the vertices of the triangular graph plot (See Figure 1A).
The exact test of population differentiation did not reveal
differences in allele and genotype frequencies between MS and
NMO patients. Similarly, no significant differences were observed
when patients were compared to controls. The PCA plot, which
unveils similarities and dissimilarities among populations, showed
that the cumulative percentage of the variance explained by the
first three components was 94.51, which means that 94.5% of the
total variance represented by alleles of the 12 AIMs was explained
by the present principal component analysis. According to this
PCA analysis, all the studied populations clustered together next to
the ancestral European population, and were different from
African and Amerindian ancestral populations, indicating a closely
homogeneous ancestry when evaluated by this set of AIMs (see
Figure 1B).
Genetic ancestry estimates in patients and controls showed that
European contribution was preponderant in all groups, represent-
ing 68.7% in NMO and 78.5% in MS patients, whereas African
ancestry estimates reached 20.5% for NMO and 12.5% for MS
patients (see Table 2). These estimates were highly reliable as
evaluated by the large R2 values. These results are in agreement
with the principal component analysis shown in Figure 1B, and
support the idea that the Brazilian groups studied are highly
homogeneous regarding the European ancestry when assessed by
this set of 12 AIMs.
Considering both ancestral and admixed populations, African
ancestry indexes (AAIs) observed for the ancestral African and
Amerindian populations differed significantly from all other
groups (p , 0.05 for each comparison). In addition, AAI values
observed for the ancestral European population were different
Table 2. AIMs frequencies observed in MS and NMO patients and healthy controls from Ribeirao Preto (RP), and in Africans (AFR),
Europeans (EUR) and Amerindians (AMZ).
Allele frequency (%) d value
AIMs
Type/
Alleleb
Genetic
positionc
MS-RP
(n=128)
NMO-RP
(n =58)
Controls-RP
(n =108)
AFR
(n =128)
EUR
(n=88)
AMZ
(n=48)
AFR/
EUR
AFR/
AMZ
EUR/
AMZ
FY-NULL*1a (rs2814778) SNP/G 1q23.2 0.863 0.845 0.850 0.000 0.993 1.000 0.993 1.000 0.007
RB1*1 (rs2252544) SNP/G 13q14.2 0.355 0.457 0.397 0.920 0.309 0.167 0.611 0.753 0.142
LPL*1 (rs285) SNP/T 8p21.3 0.569 0.560 0.584 0.980 0.529 0.478 0.451 0.502 0.051
AT3*1 (rs3138521) Indel/Ins 1q25.1 0.310 0.483 0.421 0.860 0.279 0.021 0.581 0.839 0.258
APOA1*1 (rs3138522) Alu/Ins 11q23.3 0.883 0.888 0.874 0.453 0.919 0.990 0.466 0.537 0.071
PV92*1 (rs3138523) Alu/Ins 16q24.1 0.258 0.310 0.336 0.187 0.110 0.935 0.077 0.748 0.825
CKM*1 (rs4884) SNP/T 19q13.32 0.294 0.371 0.341 0.160 0.287 0.814 0.127 0.654 0.527
DRD2-BclI*1 (rs1079598) SNP/C 11q23.1 0.165 0.121 0.131 0.087 0.132 0.479 0.045 0.392 0.347
MID-52*1 (rs16344) Indel/Del 4q24 0.177 0.241 0.182 0.200 0.074 0.755 0.126 0.555 0.681
MID-575*1 (rs140864) Indel/Ins 1p34.3 0.081 0.078 0.075 0.873 0.993 0.564 0.120 0.309 0.429
MID-93*1 (rs16383) Indel/Del 22q13.2 0.694 0.716 0.561 0.300 0.816 0.188 0.516 0.112 0.628
SB19.3*1 (rs3138524) Alu/Ins 19p13.11 0.794 0.698 0.804 0.507 0.904 0.708 0.397 0.201 0.196
Ancestry estimates
European 0.785 6 0.002 0.687 6 0.001 0.704 6 0.012
African 0.125 6 0.001 0.205 6 0.001 0.179 6 0.007
Amerindian 0.090 6 0.001 0.108 6 0.001 0.117 6 0.009
R2 = 0.9999 R2 = 0.9999 R2 = 0.9992
Significant differences (d . 0.30) between ancestral populations are underlined in the last columns. European, African and Amerindian ancestry contributions and
respective R2 values are shown at the bottom of the Table.
aAncestry informative marker *1 alleles with their reference sequence number from database of National Center for Biotechnological Information (dbSNP/NCBI).
bSingle nucleotide polymorphism (SNP), insertion/deletion (Indel), and Alu insertion (Alu) polymorphism / allele that characterizes the *1 allele.
cChromosomal location of each AIM.
doi:10.1371/journal.pone.0058925.t002
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from the MS-RP, NMO-RP, NMO-BH, NMO-PE and CTL-RP
(p , 0.05 for each comparison), but closely similar to those
observed for NMO-GO and NMO-SP (p . 0.05 for each
comparison). In contrast, AAIs observed for MS-RP, NMO
groups and for CTL-RP was closely similar among them (p .
0.05) (see Figure 2).
Discussion
To our knowledge, this is the first study using AIMs to
investigate the European, Amerindian, and African genetic
ancestry contribution in NMO. The statement that NMO and
MS are predominantly associated with either one genetic ancestry
or the other is based mainly on our visual perception of phenotype
traits from patients and not from the ancestry background. In the
present study, we have shown that the contributions of these
ancestral groups only present minor differences between NMO
and MS patients, and that European contribution predominates in
patients of both diseases. Furthermore, the PCA plot showed that
NMO groups from different Brazilian regions were clustered close
to the European population. In addition, the AAI values for
individuals of the NMO groups and of MS-RP did not differ, i.e.,
their African ancestry was similar. This finding raises questions
regarding NMO ancestry, stating that …neuromyelitis optica is
relatively common in non-Whites and populations with a minor
European contribution to their genetic composition such as Afro-
Brazilian [12]. Noteworthy, it is important to emphasize that skin
color may not be a reliable marker for genome ancestry, since a
previous Brazilian study evaluating 10 AIMs showed that skin
color, as determined by physical examination, is a poor predictor
of genomic ancestry [13]. In addition, the further evaluation of 40
AIMs in Brazilian subjects from different regions showed that
European ancestry was predominant [14].
Despite the small number of AIMs and of small numbers the
individuals analyzed, this study discriminated the ancestral groups
contributions and indicated that even small number of markers
may be sufficient when appropriately selected to answer a specific
question. Taken together, these findings support the evidence that
phenotypic traits do not reliably reflect the genomic ancestry of
NMO and MS individuals
In conclusion, this is the first study demonstrating that the
European gene pool predominates in NMO patients. New insights
from the contribution of the ancestral populations in NMO and
MS patients may support a better understanding of the differential
ancestry prevalence in disease and may help advance the use of
genomic medicine.
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Figure 2. African ancestry indexes (AAI) distribution for
ancestral populations, multiple sclerosis (MS) and neuromy-
elitis optica (NMO) patients. Distribution of African ancestry Index
(AAI) for Africans (AFR-green), Amerindians (AMZ-blue) and Europeans
(EUR-red) in NMO patients from several Brazilian regions [Southeastern:
Ribeira˜o Preto (NMO-RP), Sa˜o Paulo (NMO-SP) and Belo Horizonte
(NMO-BH); Central:-Goiaˆnia (NMO-GO), and Northeastern: (Recife-
Pernambuco (NMO-PE)]; in MS patients from Ribeira˜o Preto (MS-RP);
and in healthy controls from Ribeira˜o Preto (CTRL-RP).
doi:10.1371/journal.pone.0058925.g002
Figure 1. Information of ancestry informative markers (AIMs) set for ancestral populations, multiple sclerosis (MS) and
neuromyelitis optica (NMO) patients. (A) The panel of 12 ancestry informative markers (AIMs) for Africans (green), Europeans (red) and
Amerindians (blue) were sufficient for an adequate discrimination among ancestral populations. (B) Principal components analysis (PCA) for NMO
[Southeastern: Ribeira˜o Preto (NMO-RP), Sa˜o Paulo (NMO-SP) and Belo Horizonte (NMO-BH); Central:-Goiaˆnia (NMO-GO), and Northeastern: (Recife-
Pernambuco (NMO-PE)] and MS patients from Ribeira˜o Preto (MS-RP) and control individuals from Ribeira˜o Preto (CTRL-RP) together with ancestral
populations [Africans (green), Europeans (red) and Amerindians (blue)], showing that they clustered closer to Europeans than to Africans and
Amerindians.
doi:10.1371/journal.pone.0058925.g001
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